May your side effects stay mild, your adaptation stay swift, and your protocols stay informed.
Ren X, Zou L, Zhang X, Branco V, Wang J, Carvalho C, et al
Obesity has been implicated as promoting cardiovascular disease, diabetes, hypertension, and other complications, suggesting that sustained, effective weight loss may have independent cardiovascular benefit [13] [14]
Patients often mix these names up, so heres the short version: Semaglutide (Ozempic for diabetes, Wegovy for weight loss) activates one receptor GLP-1
00:14:06 Narrator Thanks for listeningwe hope todays episode gave you practical insights you can use right away